“Exclusively funds Phase I and Phase II cancer clinical trials for patients of all ages, across all cancer types. At the vanguard of discovery science, early-phase research is the first step in developing new treatments and therapies, and is often underfunded by traditional sources.”
Funding Phase I and II patient-centered clinical trials focusing on the following priority research areas:
- Biomarkers/Molecular Markers (genomic or proteomic)
- Gene Therapy
- Histology Agnostic/Basket Trial
- Targeted Therapies
Focus is on the following therapeutic areas:
- New Investigational Therapies
- Novel Use or Approach
- Precision Medicine
- Integrative Medicine
Gateway seek to bring urgency to the process of cancer research for those patients who are looking for treatments today and are faced with difficult decisions without innovative live-saving options. Gateway will place increasing emphasis on the funding patient centered and novel research that includes approaches with a high potential for success.
Closes Feb 1 2022. https://gatewaycr.smapply.org/
Stepwise application process with Letter of Intent outcome in 7 days.